Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate pathology: histologic and molecular perspectives.

M J Putzi1, A M De Marzo

  • 1Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Hematology/Oncology Clinics of North America
|August 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upregulated MYC expression and p53 mutations may contribute to the oncogenesis of canine Meibomian gland carcinomas.

Veterinary pathology·2022
Same author

Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.

Journal of comparative pathology·2019
Same author

Diagnostic Utility of Cytokeratin-5 for the Identification of Proliferative Inflammatory Atrophy in the Canine Prostate.

Journal of comparative pathology·2018
Same author

In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading.

Virchows Archiv : an international journal of pathology·2016
Same author

Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.

Prostate cancer and prostatic diseases·2015
Same author

Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion.

Prostate cancer and prostatic diseases·2013
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Prostate cancer research advances will improve diagnosis and treatment prediction. Understanding prostate cancer development and prevention strategies are key research areas.

Area of Science:

  • Oncology
  • Urology
  • Cancer Research

Background:

  • Prostate cancer diagnosis and prognosis prediction require improvement.
  • Histopathologic and molecular analyses are crucial for understanding prostate cancer.
  • The high incidence of prostate cancer necessitates further research into its development.

Purpose of the Study:

  • To highlight the potential for significant advancements in prostate cancer research.
  • To emphasize the importance of diagnostic and prognostic tools in prostate cancer care.
  • To underscore the need for understanding prostate carcinogenesis for prevention strategies.

Main Methods:

  • Review of current histopathologic and molecular analyses in prostate cancer research.
  • Analysis of mechanisms underlying prostate cancer development.

Related Experiment Videos

  • Exploration of factors contributing to the prostate's susceptibility to cancer.

    • Main Results:

    • Anticipated improvements in diagnosing men at risk for prostate cancer.
    • Enhanced ability to predict prognosis and treatment response.
    • Potential for developing rational disease prevention strategies based on new insights.

    Conclusions:

    • Histopathologic and molecular analyses are central to improving prostate cancer diagnosis and treatment.
    • Understanding the mechanisms of prostate carcinogenesis is vital for prevention.
    • Future research holds promise for transforming prostate cancer management and prevention.